Safety and efficacy of menin inhibition in patients (PTS) with mll-rearranged and npm1 mutant acute leukemia: A phase (PH) 1, first-in-human study of sndx-5613 (augment 101)

Category Primary study
JournalBlood
Year 2021
This article has no abstract
Epistemonikos ID: caf28223d1198eee0127d2c9a96c7b17ca9994ff
First added on: Feb 13, 2025